5PSQ-016 Safe use of antiplatelet medication: approaching the optimal dose of aspirin by pharmaceutical intervention

BACKGROUND: Based on available evidence and its benefit/risk balance, acetylsalicylic acid (ASA) is the first-line antiplatelet drug of choice for secondary prevention of cardiovascular events. It is recommended to be used at low doses, not exceeding 150 mg/day. This dosage has proved to be effectiv...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Hosp Pharm
Hlavní autoři: López-Álvarez, C, Ruiz-Fuentes, S, Domínguez-Recio, A, Blanco-Bermejo, C
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2018
Témata:
Section 5: Patient safety and quality assurance
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535577/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.370
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky